Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis

LM Caiano, N Riva, W Ageno - Expert Review of Hematology, 2023 - Taylor & Francis
Introduction Liver cirrhosis is accompanied by several hemostatic alterations, which
contribute to the current theory of “rebalanced hemostasis.” Splanchnic vein thrombosis …
被引用次数：3 相关文章

Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis

LM Caiano, N Riva, W Ageno - EXPERT REVIEW OF …, 2023 - irinsubria.uninsubria.it
Introduction: Liver cirrhosis is accompanied by several hemostatic alterations, which
contribute to the current theory of “rebalanced hemostasis.” Splanchnic vein thrombosis …

Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis

LM Caiano, N Riva, W Ageno - Expert review of …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Liver cirrhosis is accompanied by several hemostatic alterations, which
contribute to the current theory of" rebalanced hemostasis." Splanchnic vein thrombosis …

Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis.

LM Caiano, N Riva, W Ageno - Expert Review of Hematology, 2023 - europepmc.org
Liver cirrhosis is accompanied by several haemostatic alterations, which contribute to the
current theory of" rebalanced haemostasis". Splanchnic vein thrombosis (SVT) is a frequent …

Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis

LM Caiano, N Riva, W Ageno - 2023 - um.edu.mt
Expert opinion: Early anticoagulant therapy is recommended in cirrhotic patients with acute
SVT, to obtain vessel recanalization and decrease the rates of portal hypertension-related …